Ecarin clotting time: Difference between revisions

Jump to navigation Jump to search
No edit summary
 
m (Bot: Automated text replacement (-{{SIB}} + & -{{EJ}} + & -{{EH}} + & -{{Editor Join}} + & -{{Editor Help}} +))
 
Line 3: Line 3:
{{CMG}}
{{CMG}}


{{EH}}
 


'''Ecarin clotting time''' (ECT) is a laboratory test used to monitor anticoagulation during treatment with [[hirudin]], an [[anticoagulant]] [[medication]] which was originally isolated from [[leech]] saliva as well as the direct thrombin inhibitor [[dabigatran]] or [[pradaxa]]. Ecarin, the primary reagent in this assay, is derived from the venom of the saw-scaled viper, ''Echis carinatus''.  
'''Ecarin clotting time''' (ECT) is a laboratory test used to monitor anticoagulation during treatment with [[hirudin]], an [[anticoagulant]] [[medication]] which was originally isolated from [[leech]] saliva as well as the direct thrombin inhibitor [[dabigatran]] or [[pradaxa]]. Ecarin, the primary reagent in this assay, is derived from the venom of the saw-scaled viper, ''Echis carinatus''.  
Line 14: Line 14:
</div>
</div>


{{SIB}}
 


[[Category:Hematology]]
[[Category:Hematology]]

Latest revision as of 02:05, 9 August 2012

Saw-scaled viper, Echis carinatus.

WikiDoc Resources for Ecarin clotting time

Articles

Most recent articles on Ecarin clotting time

Most cited articles on Ecarin clotting time

Review articles on Ecarin clotting time

Articles on Ecarin clotting time in N Eng J Med, Lancet, BMJ

Media

Powerpoint slides on Ecarin clotting time

Images of Ecarin clotting time

Photos of Ecarin clotting time

Podcasts & MP3s on Ecarin clotting time

Videos on Ecarin clotting time

Evidence Based Medicine

Cochrane Collaboration on Ecarin clotting time

Bandolier on Ecarin clotting time

TRIP on Ecarin clotting time

Clinical Trials

Ongoing Trials on Ecarin clotting time at Clinical Trials.gov

Trial results on Ecarin clotting time

Clinical Trials on Ecarin clotting time at Google

Guidelines / Policies / Govt

US National Guidelines Clearinghouse on Ecarin clotting time

NICE Guidance on Ecarin clotting time

NHS PRODIGY Guidance

FDA on Ecarin clotting time

CDC on Ecarin clotting time

Books

Books on Ecarin clotting time

News

Ecarin clotting time in the news

Be alerted to news on Ecarin clotting time

News trends on Ecarin clotting time

Commentary

Blogs on Ecarin clotting time

Definitions

Definitions of Ecarin clotting time

Patient Resources / Community

Patient resources on Ecarin clotting time

Discussion groups on Ecarin clotting time

Patient Handouts on Ecarin clotting time

Directions to Hospitals Treating Ecarin clotting time

Risk calculators and risk factors for Ecarin clotting time

Healthcare Provider Resources

Symptoms of Ecarin clotting time

Causes & Risk Factors for Ecarin clotting time

Diagnostic studies for Ecarin clotting time

Treatment of Ecarin clotting time

Continuing Medical Education (CME)

CME Programs on Ecarin clotting time

International

Ecarin clotting time en Espanol

Ecarin clotting time en Francais

Business

Ecarin clotting time in the Marketplace

Patents on Ecarin clotting time

Experimental / Informatics

List of terms related to Ecarin clotting time

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]


Ecarin clotting time (ECT) is a laboratory test used to monitor anticoagulation during treatment with hirudin, an anticoagulant medication which was originally isolated from leech saliva as well as the direct thrombin inhibitor dabigatran or pradaxa. Ecarin, the primary reagent in this assay, is derived from the venom of the saw-scaled viper, Echis carinatus.

In the clinical assay, a known quantity of eccarin is added to the plasma of a patient treated with hirudin. Ecarin activates prothrombin through a specific proteolytic cleavage, which produces meizothrombin, a prothrombin-thrombin intermediate which retains the full molecular weight of prothrombin, but possses a low level of procoagulant enzymatic activity. Crucially, this activity is inhibited by hirudin and other direct thrombin inhibitors, but not by heparin. The ECT is also unaffected by prior treatment with coumadin or the presence of phospholipid-dependant anticoagulants, such as lupus anticoagulant. Thus, the ECT is prolonged in a specific and linear fashion with increasing concentrations of hirudin.[1][2][3]

References

  1. Nowak G (2003). "The ecarin clotting time, a universal method to quantify direct thrombin inhibitors". Pathophysiol. Haemost. Thromb. 33 (4): 173–83. doi:10.1159/000081505. PMID 15583446.
  2. Fabrizio MC. 2001. Use of Ecarin Clotting Time (ECT) with Lepirudin Therapy in Heparin-Induced Thrombocytopenia and Cardiopulmonary Bypass. JECT 33:117–125. PDF at Journal of The American Society of ExtraCorporeal Technology. Accessed 5 June 2007.
  3. Textarin/Ecarin Time at Specialty Laboratories. Accessed 5 June 2007.

Template:WikiDoc Sources